Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan

P. WU (Yun-Lin, Taiwan), Y. Chen (Yun-Lin, Taiwan), C. Lin (Yun-Lin, Taiwan)

Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Session: Preclinical and clinical studies of critical illness
Session type: Thematic Poster
Number: 2325
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. WU (Yun-Lin, Taiwan), Y. Chen (Yun-Lin, Taiwan), C. Lin (Yun-Lin, Taiwan). Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan. 2325

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018

Management of community-acquired pneumonia in primary care: an observational study
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019


Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017
Year: 2018



Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Predictive factors for multidrug-resistant pathogens in hemodialysis patients with pneumonia : a multicenter study
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017


Association of acinetobacter baumannii respiratory isolates with hospital outcomes in ventilated patients
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006

The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units- A prospective cohort observational study
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016

Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010

GRACE-01 Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe – a multicentre, observational cohort study of cough/LRTI in primary care
Source: Annual Congress 2007 - Clinical trial: antibiotic use in the community
Year: 2007


The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Pediatric multidrug-resistant tuberculosis in Belgium: a nationwide retrospective cohort study.
Source: International Congress 2017 – Update on TB: latest news
Year: 2017




A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience
Source: Eur Respir J 2005; 26: Suppl. 49, 222s
Year: 2005

Bacterial respiratory co-infections of patients hospitalized with COVID-19: a prospective microbiologic study in single tertiary hospital in Kazakhstan
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021

Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study
Source: Eur Respir J, 54 (1) 1900057; 10.1183/13993003.00057-2019
Year: 2019



Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018
Year: 2018